Short answer
Edwards Lifesciences (EW) filed an 8-K current report with the SEC on May 8, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved amended Long-Term Stock Incentive Compensation Program.
Edwards Lifesciences 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Stockholders approved amended Long-Term Stock Incentive Compensation Program
- Share authorization increased by 7,000,000 shares to 341,500,000 total
- Expanded equity pool supports future employee retention and incentive awards
- Potential shareholder dilution from additional issuable shares
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All nine director nominees elected, preserving board continuity through the next annual meeting
- Executive compensation advisory vote approved, with 424,961,639 shares for and 50,924,101 against
- PwC auditor appointment ratified for fiscal year ending December 31, 2026
- Amended long-term stock incentive program approved, with 456,675,201 shares for and 19,210,539 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Edwards Lifesciences 8-K filings
Get the next EW 8-K as it lands
Follow EW for push alerts, or ask the research agent what this filing means.